COVID-19 treatments for non-cancer and cancer patients with COVID-19
| Treatment | Non-cancer patients with COVID-19 | Cancer patients with COVID-19 |
|---|---|---|
| Oxygen therapy | Oxygen support | Oxygen support |
| High-flow nasal cannula | Invasive mechanical ventilation | |
| Prone position ventilation | Endotracheal intubation and invasive ventilation | |
| Extracorporeal membrane oxygenation24,27 | Extracorporeal membrane oxygenation5,6,14 | |
| Antiviral therapy | Remdesivir | Oseltamivir |
| Arbidol | Umifenovir | |
| Chloroquine | Arbidol | |
| Lopinavir/ritonavir | Lopinavir/ritonavir | |
| Nucleoside analogues | Ganciclovir | |
| Neuraminidase inhibitors24,25,28–30 | Ribavirin5,6,14 | |
| Immune enhancement therapy | Interferon | Interferon |
| Intravenous immunoglobulin | Intravenous immunoglobulin5,14 | |
| Thymosin alpha-125,31 | ||
| Anti-inflammatory therapy | Corticosteroid | Systemic corticosteroid |
| Methylprednisolone | Tocilizumab5,6,14,34 | |
| Dexamethasone | ||
| Blood purification therapy | ||
| Tocilizumab and sariluma | ||
| Siltuximab | ||
| Prazosin31–35 | ||
| Convalescent plasma therapy | Convalescent plasma therapy | No relative reports |
| Plasma globulin specific to SARS-CoV-225,31 | The safety and the efficacy need further evaluation |